Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice - Test2 - elhamkhani - TriplyDB

Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice

Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice

http://www.wikidata.org/entity/Q28169162

about

International Society of Sports Nutrition position stand: creatine supplementation and exercise Creatine for women in pregnancy for neuroprotection of the fetus Creatine for treating muscle disorders Creatine for women in pregnancy for neuroprotection of the fetus Creatine for treating muscle disorders Creatine for treating muscle disorders Creatine supplementation during pregnancy: summary of experimental studies suggesting a treatment to improve fetal and neonatal morbidity and reduce mortality in high-risk human pregnancy Creatine kinase in ischemic and inflammatory disorders The creatine kinase/creatine connection to Alzheimer's disease: CK-inactivation, APP-CK complexes and focal creatine deposits The membrane-active tri-block copolymer pluronic F-68 profoundly rescues rat hippocampal neurons from oxygen-glucose deprivation-induced death through early inhibition of apoptosis Mitochondrial therapy for Parkinson's disease: neuroprotective pharmaconutrition may be disease-modifying Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research.International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.A potential role for creatine in drug abuse?Dipyrone inhibits neuronal cell death and diminishes hypoxic/ischemic brain injury Therapeutic use of creatine in brain or heart ischemia: available data and future perspectives.Caffeine and creatine use in sport.A review of creatine supplementation in age-related diseases: more than a supplement for athletes.The biological basis of injury and neuroprotection in the fetal and neonatal brain.Creatine pretreatment protects cortical axons from energy depletion in vitro.Huntington's disease: progress and potential in the field.Mitochondrial approaches for neuroprotection Mitochondria: a therapeutic target in neurodegeneration Creatine in mouse models of neurodegeneration and aging.Creatine as a therapeutic strategy for myopathies.Beyond muscles: The untapped potential of creatine.Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease.Global and targeted gene expression and protein content in skeletal muscle of young men following short-term creatine monohydrate supplementation.Hypoxia decreases creatine uptake in cardiomyocytes, while creatine supplementation enhances HIF activation.Overexpression of mitochondrial Hsp70/Hsp75 in rat brain protects mitochondria, reduces oxidative stress, and protects from focal ischemia.Supplementation of creatine and ribose prevents apoptosis in ischemic cardiomyocytes.Nortriptyline protects mitochondria and reduces cerebral ischemia/hypoxia injury.Modulation of intracellular ATP determines adenosine release and functional outcome in response to metabolic stress in rat hippocampal slices and cerebellar granule cells.Creatine supplementation reduces doxorubicin-induced cardiomyocellular injury.Creatine supplementation improves dopaminergic cell survival and protects against MPP+ toxicity in an organotypic tissue culture system.Evidence that quinolinic acid severely impairs energy metabolism through activation of NMDA receptors in striatum from developing rats.Improved reperfusion and neuroprotection by creatine in a mouse model of stroke.Biochemical characterization of a Caspase-3 far-red fluorescent probe for non-invasive optical imaging of neuronal apoptosis.Effect of creatine monohydrate supplementation on various hematological and serum biochemical parameters of male albino mice following neonatal hypoxia-ischemia encephalopathy.

P2860

Q21245421-964C6C66-E7A9-4EF9-A364-84B2A85AD10D Q24187191-FA87F319-8330-4FAC-9DD7-0F9DCEBBCB47 Q24202243-FC25A9BB-86C4-4D34-A3D4-1B303497B8EF Q24202668-583C0ED5-7658-4285-88C2-880B5D9FC96F Q24236598-EF33C4DA-81F2-46B9-BA4E-4F73781FD4FD Q24246414-49F4C1F0-DAB9-44CE-BB0A-C408F13127B8 Q27006952-C0304EF3-7C2B-4727-A3B1-64B44E8B3E6C Q28069271-2D8C4780-271C-4DF4-828B-F8F216E083F5 Q28200789-35CC1B79-85ED-4EE4-A581-30A218C5FF1B Q28386144-F111BD0B-96CF-4344-BDF3-079C7791B853 Q28732683-D10FECE5-A466-4EBB-9A20-A367F6B74270 Q30995022-DEE193F3-B92C-455C-A3F4-A51549ACE8F6 Q33791877-08F81B48-DAEE-48EF-9ED9-664E8B7A9620 Q33837238-78A7E614-3D55-463C-A758-42ED6DB78477 Q33844763-52286C24-1162-4C34-849C-7BCCD24B07F9 Q33892305-AC3F4E1D-887D-4ECD-B175-54F45BEADAC1 Q34089086-4DB2FE72-8B39-440F-8106-008474E0DFD1 Q34166487-5B601DE9-3C7C-45A9-92BC-BD43D6F07C2F Q35005568-431BD70A-45C5-4E5D-9703-E1FF25521203 Q35201430-5E717112-3673-4B9F-9786-EF22B1E9D3EF Q36007434-A3BB2EAA-1865-41CA-B23F-47E795771BD8 Q37016096-FA245CD9-D7EF-4505-AB5F-A205EE8670C4 Q37348590-5FF0D946-168F-4A71-9FAB-15EAA8A75DC3 Q37466059-13B4C524-53E0-4843-9DDA-EAA66F17AC2A Q37851389-3E22DB16-581D-490C-A3B4-D75A2619A91B Q37852586-8BD7087D-1675-480E-93CD-3431A96FCD72 Q38700215-54BC38A4-8276-44D6-9CA3-FD72402CCB46 Q38706110-7C68971F-DE65-44B7-AD68-43D08D44AE8A Q39100609-80242068-B389-4AB4-B249-26F73C9A4B79 Q41600066-A739903E-5449-41D7-8DAF-2CEC698C553F Q42146138-03AF0DD9-1F7F-4411-B4C8-EE40A0E12CB9 Q42759674-1FFFD030-37E9-4C66-80D3-39C7510AB4BC Q43191415-B9CCE356-92E0-4B20-B5E1-667871652E17 Q44441170-F6F74B29-393C-4326-9030-30717A85DB6E Q46834237-A5CB7436-BB64-4CE0-9E18-E92414211BE9 Q46851841-48CE3A29-858D-415C-B401-C3857702AF4A Q48306465-5F9AD59C-9698-43A1-875B-122868EA74E0 Q48497589-9A6C139D-D204-4935-9C84-93C6F62FA01F Q48763774-64A5A5F0-2C54-4BA6-B2A2-6EB33B57312F Q53084832-3D98CCC3-33DF-4E69-9AD7-2FFE400FE304

P2860

Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice

http://www.wikidata.org/entity/Q28169162

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Prophylactic creatine administ ...... n in cerebral ischemia in mice

@ast

Prophylactic creatine administ ...... n in cerebral ischemia in mice

@en

Prophylactic creatine administ ...... n in cerebral ischemia in mice

@nl

type

label

Prophylactic creatine administ ...... n in cerebral ischemia in mice

@ast

Prophylactic creatine administ ...... n in cerebral ischemia in mice

@en

Prophylactic creatine administ ...... n in cerebral ischemia in mice

@nl

prefLabel

Prophylactic creatine administ ...... n in cerebral ischemia in mice

@ast

Prophylactic creatine administ ...... n in cerebral ischemia in mice

@en

Prophylactic creatine administ ...... n in cerebral ischemia in mice

@nl

P1433

Q28169162-56EAB2F7-BE34-4AF7-B6AF-4F539F16FB04

P1476

Q28169162-BB40E1CA-820C-4D4A-B66F-9620C85A91D6

P2093

Q28169162-361A921F-8A4C-4629-81D8-039BAB7D52E7

Q28169162-37B48289-C1D6-467C-B392-FDCC550F7F2F

Q28169162-4FE12FA4-A220-47D1-871E-DA7844B779C5

Q28169162-5D594B82-23E8-4FDC-9DA1-461C5591FBA5

Q28169162-77D228AC-26E0-4795-B462-04A12E8584B8

Q28169162-86FCD838-AACB-4714-96B8-DED1F0A9DEE2

Q28169162-97FC303D-E824-409A-A1CE-63A1B55A54E7

Q28169162-EF6A7B1A-3B55-451E-BD48-0540CF81C71D

Q28169162-F1E64F2E-DAEE-4458-84B2-83EDB78F6085

Q28169162-F5CD5261-D3DA-4ADD-AED6-AFD18337E7AC

P304

Q28169162-5D4C83B8-3E76-4D75-885F-DEDA79E8C7C6

P31

Q28169162-3E969843-3689-4F3D-A83C-6AF18CB65CBB

P3181

Q28169162-E4E8BDA2-3256-4DF2-88D4-951C1928EBF8

P356

Q28169162-E876ED35-52FB-414D-8A77-F6336715D2B6

P407

Q28169162-A8813A9F-B3FF-47CB-98C5-C89C89F02BD1

P433

Q28169162-814B31BF-6D79-43AC-A68B-68D005B3AC9C

P478

Q28169162-188B1E1B-9FA9-4FBD-91D1-8936C6ABBEE9

P50

Q28169162-7E58C642-22EE-43BA-8D53-26CE0D778012

Q28169162-9BEC2B61-2884-462C-A292-FD9ABF796814

P577

Q28169162-18EB05D2-670B-40E4-B514-0C10B7640675

P5875

Q28169162-8201E57C-8CC9-4C88-9CFB-97581BC8CF77

P698

Q28169162-17993F82-3EBC-4E1E-823C-FA284134FA03

P921

Q28169162-00EF267B-A208-442C-A6D1-BF17B5E4EC1C

P932

Q28169162-9CDBEEA8-5766-4BE1-8D88-5D5FD50E0345

P3181

P356

JNEUROSCI.1278-04.2004

P1433

Journal of Neuroscience

P1476

Prophylactic creatine administ ...... n in cerebral ischemia in mice

@en

P2093

Aijian Liu

http://www.w3.org/2001/XMLSchema#string

Bruce S Kristal

http://www.w3.org/2001/XMLSchema#string

Bryan E Figueroa

http://www.w3.org/2001/XMLSchema#string

Irina G Stavrovskaya

http://www.w3.org/2001/XMLSchema#string

M Flint Beal

http://www.w3.org/2001/XMLSchema#string

Mingwei Li

http://www.w3.org/2001/XMLSchema#string

Piera Pasinelli

http://www.w3.org/2001/XMLSchema#string

Robert J Ferrante

http://www.w3.org/2001/XMLSchema#string

Robert M Friedlander

http://www.w3.org/2001/XMLSchema#string

Shan Zhu

http://www.w3.org/2001/XMLSchema#string

P304

5909-5912

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4082038

http://www.w3.org/2001/XMLSchema#string

P356

10.1523/JNEUROSCI.1278-04.2004

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Robert J Ferrante

P577

2004-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8479737

http://www.w3.org/2001/XMLSchema#string

P698

15229238

http://www.w3.org/2001/XMLSchema#string

P921

cerebral infarction

P932

6729248

http://www.w3.org/2001/XMLSchema#string